Related references
Note: Only part of the references are listed.Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium
Michael Goggins et al.
GUT (2020)
Early Detection of Pancreatic Cancer: Opportunities and Challenges
Aatur D. Singhi et al.
GASTROENTEROLOGY (2019)
Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance
Marcia Irene Canto et al.
GASTROENTEROLOGY (2018)
Model to Determine Risk of Pancreatic Cancer in Patients With New-Onset Diabetes
Ayush Sharma et al.
GASTROENTEROLOGY (2018)
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
T. Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Life Expectancy and Cause-Specific Mortality in Type 2 Diabetes: A Population-Based Cohort Study Quantifying Relationships in Ethnic Subgroups
Alison K. Wright et al.
DIABETES CARE (2017)
Imaging modalities in the diagnosis of pancreatic adenocarcinoma: A systematic review and meta- analysis of sensitivity, specificity and diagnostic accuracy
James Toft et al.
EUROPEAN JOURNAL OF RADIOLOGY (2017)
A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset Diabetes
Ben Boursi et al.
GASTROENTEROLOGY (2017)
Comparison of treatment patterns, resource utilization, and cost of care in patients with metastatic pancreatic cancer treated with first-line nab-paclitaxel plus gemcitabine or FOLFIRINOX
George P. Kim et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2017)
Health-Related Quality of Life in Patients with Metastatic Pancreatic Cancer
Vincent Picozzi et al.
JOURNAL OF GASTROINTESTINAL CANCER (2017)
Cost Effectiveness of Metal Stents in Relieving Obstructive Jaundice in Patients with Pancreatic Cancer
J. M. Martinez et al.
JOURNAL OF GASTROINTESTINAL CANCER (2017)
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses Second Panel on Cost-Effectiveness in Health and Medicine
Gillian D. Sanders et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Is screening for pancreatic cancer in high-risk groups cost-effective? - Experience from a Danish national screening program
Maiken Thyregod Joergensen et al.
PANCREATOLOGY (2016)
Impact of country-specific EQ-5D-3L tariffs on the economic value of systemic therapies used in the treatment of metastatic pancreatic cancer
K. Lien et al.
CURRENT ONCOLOGY (2015)
Preoperative endoscopic ultrasound-guided fine needle aspiration does not impair survival of patients with resected pancreatic cancer
Saowanee Ngamruengphong et al.
GUT (2015)
Cost-effectiveness analysis of gemcitabine, S-1 and gemcitabine plus S-1 for treatment of advanced pancreatic cancer based on GEST study
Jing Zhou et al.
MEDICAL ONCOLOGY (2015)
Cost-utility analysis of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in combination with gemcitabine in metastatic pancreatic cancer in Spain: results of the PANCOSTABRAX study
Alfredo Carrato et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2015)
Cost-Effectiveness Analysis of Endoscopic Ultrasound versus Magnetic Resonance Cholangiopancreatography in Patients with Suspected Common Bile Duct Stones
Stephen Morris et al.
PLOS ONE (2015)
Cost-effectiveness of FOLFIRINOX for first-line treatment of metastatic pancreatic cancer
C. L. Attard et al.
CURRENT ONCOLOGY (2014)
Updating Cost-Effectiveness - The Curious Resilience of the $50,000-per-QALY Threshold
Peter J. Neumann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Review of Utility Values for Economic Modeling in Type 2 Diabetes
Amelie Beaudet et al.
VALUE IN HEALTH (2014)
The Cost-Effectiveness of Neoadjuvant Chemoradiation is Superior to a Surgery-First Approach in the Treatment of Pancreatic Head Adenocarcinoma
Daniel E. Abbott et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Modelling the benefits of early diagnosis of pancreatic cancer using a biomarker signature
Ola Ghatnekar et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
New insights into pancreatic cancer-induced paraneoplastic diabetes
Raghuwansh P. Sah et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
How Good Is Endoscopic Ultrasound-Guided Fine-Needle Aspiration in Diagnosing the Correct Etiology for a Solid Pancreatic Mass? A Meta-Analysis and Systematic Review
Srinivas R. Puli et al.
PANCREAS (2013)
Cost-effectiveness of Treatment Strategies for Pancreatic Head Adenocarcinoma and Potential Opportunities for Improvement
Daniel E. Abbott et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Cost-effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer
James D. Murphy et al.
CANCER (2012)
Costs and Trends in Pancreatic Cancer Treatment
Caitriona B. O'Neill et al.
CANCER (2012)
Health Utility Scores for People With Type 2 Diabetes in U.S. Managed Care Health Plans Results from Translating Research Into Action for Diabetes (TRIAD)
Ping Zhang et al.
DIABETES CARE (2012)
Management of Patients with Pancreatic Adenocarcinoma: National Trends in Patient Selection, Operative Management, and Use of Adjuvant Therapy
Skye C. Mayo et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2012)
Assessment of morbidity and mortality associated with EUS-guided FNA: a systematic review
Kai-Xuan Wang et al.
GASTROINTESTINAL ENDOSCOPY (2011)
Intravoxel Incoherent Motion MRI for the Differentiation Between Mass Forming Chronic Pancreatitis and Pancreatic Carcinoma
Miriam Klauss et al.
INVESTIGATIVE RADIOLOGY (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Cost-Utility Estimation of Surgical Treatment of Pancreatic Carcinoma Aimed at Cure
David Ljungman et al.
WORLD JOURNAL OF SURGERY (2011)
Health-related quality of life in diabetes: The associations of complications with EQ-5D scores
Oddvar Solli et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2010)
Using economic analysis to evaluate the potential of multimodality therapy for elderly patients with locally advanced pancreatic cancer
Monika K. Krzyzanowska et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
A clinical and economic evaluation of endoscopic ultrasound for patients at risk for familial pancreatic adenocarcinoma
Joel H. Rubenstein et al.
PANCREATOLOGY (2007)
Health-related quality of life in patients with pancreatic cancer
J. Mueller-Nordhorn et al.
DIGESTION (2006)
US valuation of the EQ-5D health states - Development and testing of the D1 valuation model
JW Shaw et al.
MEDICAL CARE (2005)
Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62)
P Clarke et al.
MEDICAL DECISION MAKING (2002)
Share Paper
